In disputes over Canada’s Medical Assistance in Dying (MAiD), the fulcrum is almost never ideology; it is the paper and the bedside — what the records say about consent and capacity, and what actually happened in the final minutes when a clinician must either confirm a patient’s wishes or stop.
The Short Version
- The Stegemann case turns on whether final, informed consent existed at the bedside and whether she retained decision-making capacity when MAiD was administered.
- Her family alleges she opposed euthanasia on faith grounds, tried to withdraw, lacked capacity, and that her power of attorney was bypassed; they have filed a complaint seeking a coroner’s MAiD Death Review.
- Practitioners are reported to maintain she legally consented, and Ontario’s rules require robust documentation of eligibility, safeguards, and any waiver of final consent.
- Canadian law defaults to contemporaneous, direct consent; the narrow “waiver of final consent” applies only under strict conditions and cannot be used if the person shows refusal or resistance at provision.
What is actually at issue: consent, capacity, and contemporaneity
The family of 83-year-old Brigitte “GG” Stegemann alleges she did not provide clear final consent on the morning of the MAiD procedure, resisted at the bedside, and lacked the mental capacity required to authorize euthanasia at that time. They say she had previously rejected MAiD on religious grounds and have asked Ontario’s Chief Coroner for a MAiD Death Review Team investigation, arguing that her power of attorney (POA) was ignored and that no valid, contemporaneous consent was obtained. Multiple outlets have reported the existence of that formal complaint and the family’s assertions, including the claim that staff proceeded about ten minutes after she failed to confirm consent when asked.
On the other side of the ledger, the health-care practitioners involved are reported to maintain that Stegemann legally consented to MAiD. Some coverage attributes to the attending clinician a conclusion, after a private conversation, that Stegemann was capable of making her own decisions and had consented to proceed. While the providers and facility have not issued detailed public statements, their position as summarized in reporting is that the legal requirements — consent, capacity, and documentation — were met.
How MAiD consent is supposed to work — and why “final consent” is different
Under Canada’s MAiD framework, the default rule is direct, informed consent from the patient immediately before provision; clinicians must give the person an opportunity to withdraw and must confirm consent at the bedside. There is a narrow statutory exception — often called the waiver of final consent, created by Bill C‑7 and colloquially known as Audrey’s Amendment — but it applies only when natural death is reasonably foreseeable, the individual was assessed and approved while still capable, a written arrangement was executed in advance, and, critically, the person does not demonstrate refusal or resistance at the time MAiD is administered.
Ontario’s regulator, the College of Physicians and Surgeons of Ontario (CPSO), requires that physicians document all MAiD requests, demonstrate that eligibility criteria and safeguards were met, and keep a copy of any written arrangement that waives the requirement for final express consent. Providers must also classify a case as Track 1 (death reasonably foreseeable) or Track 2 (not reasonably foreseeable) and apply the safeguards for that track without mixing them; Track 2 includes a 90‑day assessment period that cannot be short-circuited by Track 1 rules. This documentation backbone is not a bureaucratic nicety; it is the evidentiary spine for disputes like Stegemann’s.
The family’s claims and what documentation would resolve them
The family’s filing asks investigators to examine three questions: whether Stegemann had capacity at provision, whether final consent existed that morning, and whether the POA was improperly sidelined. The most direct way to resolve such disputes is through the MAiD chart: the signed written request and witness signatures; assessors’ capacity notes; the track classification; any executed waiver of final consent; and minute‑by‑minute bedside charting, including the clinician’s confirmation of consent immediately before administration or the basis for proceeding under a waiver. CPSO policy anticipates precisely this need by instructing clinicians to keep those records in the chart.
Two related issues often get conflated in public debate and are worth separating. First, a substitute decision‑maker or POA cannot consent to MAiD on behalf of an incapable person; MAiD is a personal decision requiring the patient’s own consent. Second, a third party may sign the written request at the patient’s express direction if the patient cannot physically sign — a procedural allowance that does not convert MAiD into a substitute decision. Reporting in this case reflects both realities and explains why the family’s POA claim, on its own, would not invalidate a properly documented patient consent, though it would be relevant if capacity had been lost.
Capacity at the end of life: what clinicians look for and why timing matters
Decisional capacity is not a global label; it is task‑ and time‑specific. In Ontario, a capable person must be able to understand information relevant to the decision and appreciate the reasonably foreseeable consequences of choosing or refusing a treatment. As illness advances, capacity can fluctuate over hours, even minutes. That is why the system requires contemporaneous confirmation and why the waiver of final consent exists for Track 1 cases where loss of capacity is imminent but the person has already completed the eligibility steps while capable. Even then, any sign of refusal or resistance at provision invalidates the waiver and obligates the provider to stop.
In practice, clinicians triangulate converging evidence: prior consistent statements; formal capacity assessments; the bedside conversation immediately before administration; and, when a waiver is used, the written arrangement specifying a set date and the risk of capacity loss. The structure is designed to answer the single question that matters ethically and legally: did this specific person, at this specific time, freely choose MAiD, or must we refrain because consent is absent, capacity is gone, or the patient is resisting?
Where genuine disagreement lies in the Stegemann case
The competing narratives focus on the final window before provision. The family describes confusion, attempts to back out, and non‑responsiveness when asked to confirm consent, followed by a rapid move to proceed. Practitioners, via secondary reporting, maintain that Stegemann consented and was capable. Those are testable claims if — and only if — the chart contains what CPSO policy requires: the eligibility and capacity assessments, the track designation, any executed waiver, and the contemporaneous note documenting the final consent check or the lawful basis to proceed without it. At present, the public has not seen those primary records; privacy laws and ongoing review can delay or prevent their release.
Because MAiD consent cannot be delegated, the POA allegation has force only if investigators conclude capacity was absent or final consent was not obtained at provision; in that scenario, proceeding would conflict with the legal framework. If capacity and consent are documented as present, a POA objection — even a principled one grounded in the patient’s faith tradition — does not control the outcome in Canadian law.
REPORT: Grandma euthanized against her will in Canada…
An 83-year-old woman was medically assisted to die despite allegedly showing confusion and expressing regret about the procedure, her granddaughter has claimed.
Brigitte Stegemann, who had stage four stomach cancer,… pic.twitter.com/AuPwaLaLDX
— Rifnote (@viarifnote) September 24, 2026
How to assess cases like this going forward
A clear evaluative path exists, and it does not require ideology. Investigators should examine: the written request provenance and witness details; the two independent eligibility assessments and their capacity rationales; the Track 1 or Track 2 classification and compliance with associated safeguards; any executed waiver of final consent, including risk‑of‑capacity‑loss counseling and fixed‑date specification; and bedside documentation of the immediate pre‑administration consent dialog or observed refusal/resistance. Each element has a documentary footprint under CPSO policy and federal practice standards; alignment or gaps in that footprint tell the story.
Sources:
x.com, ibtimes.co.uk, cbn.com, thecatholicherald.com, lifenews.com, en.newsner.com
